Products Category
Antibody-drug Conjugate/ADC Related
Contact Us
Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ:
2500035664
|
Product name : LY335979
Item : CRY905
CAS : 167354-41-8
 |
| Details: |
Description of:LY335979
LY335979 significantly enhanced the survival of mice implanted with Pgp-expressing murine leukemia (P388/ADR) when administered in combination with either daunorubicin, doxorubicin or etoposide. Coadministration of LY335979 with paclitaxel compared to paclitaxel alone significantly reduced the tumor mass of the Pgp-expressing UCLA-P3.003VLB lung carcinoma in a xenograph model. Theoretical analysis:LY335979 M.Wt: 527.6 Formula: C32H31F2N3O2 Solubility: Unknown Purity: >99% Storage: at -20 CAS No: 167354-41-8 Availability and price:LY335979 Pakage：25mg/50mg/100mg/250mg/500mg/1g/5g Stock : in stock We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
| Related Products : |
|
|
|
|
||||||||
|
|
|
|
Chinese
Deutsch
Espanol
Francais
Italiano
Portugues
Japanese
Korean
Arabic
Russian